Shenandoah Therapeutics Inc. — Form D

Shenandoah Therapeutics Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-15. The offering totals $21.5M, of which $21.5M was reported sold. Industry: Other Technology.

Offering

• Filed: 2025-05-15
• Form: D
• Accession: 0002068421-25-000001
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $21.5M
• Amount sold: $21.5M
• Investors: 12
• Date of first sale: 2025-05-02
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-546256

Issuer

• Name: Shenandoah Therapeutics Inc.
• CIK: 0002068421
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 329 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
• Phone: 650-239-0503

Officers, directors & promoters (7)

More

• CIK 2068421 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search